NR1H4 and neoplasm: In this experiment, the effects of FXR activation on the cell proliferation of various tumor cell lines including HepG2, SK-Hep1, and HT29, as well as primary hepatocytes, were tested by using selective FXR agonists GW4064 or CDCA18, 19.